 |
인쇄하기
취소
|
Government to opt for EP regulations over biosimilar products
The Korea Food and Drug Administration is considering adopting the European regulations and guidelines in the process of screening biosimilar products.
The health regulator says the EP regulations are less stringent than those in the United States in order to boost the domestic pharmaceutical industry.
Currently, a consultative body consisting of 27 specialists from the government and pri...
The health regulator says the EP regulations are less stringent than those in the United States in order to boost the domestic pharmaceutical industry.
Currently, a consultative body consisting of 27 specialists from the government and pri...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.